TickerFactsScreenerDevelopers

Immix Biopharma, Inc. (IMMX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2020: $391.1K2021: $17.64M2022: $13.44M2023: $17.51M2024: $17.68M2025: $93.93M$93.93M
2020Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$93.93M+431.2%
2024$17.68M+1.0%
2023$17.51M+30.3%
2022$13.44M-23.8%
2021$17.64M+4411.7%
2020$391.1K—